2 June 2021
The Global Vaccine Confidence Summit convened world leading experts to commit to greater international collaboration to build vaccine confidence globally.
Speakers at the Summit included: Matt Hancock MP, Secretary of State for Health and Social Care, UK Government, Dr Tedros Adhanom Ghebreyesus, Director General at World Health Organization (WHO), Helle Thorning-Schmidt, former Prime Minister of Denmark and former CEO of Save the Children International, and Co-Chair of Facebook’s Oversight Board.
LONDON: As part of its G7 Presidency, the UK Government convened the Global Vaccine Confidence Summit today, a first-of-its-kind event, bringing together global experts from across the public and private sector to build and maintain confidence in vaccines.
Today (27 May 2021) marks the launch of a joint project by two Italian and Austrian universities aimed at enhancing health and safety on the workplace,.
Do COVID-19 vaccines care whether you re female or male?
MSU researcher is studying, raising awareness about the role of sex in the efficacy of vaccines that make use of nanomedicine
If there’s one take-home message for the general public about the coronavirus vaccines approved in the U.S., it’s that they are remarkably effective.
MSU Assistant Professor Morteza Mahmoudi
But Michigan State University’s Morteza Mahmoudi is raising awareness about an important subtlety: The vaccines developed by Moderna and Pfizer-BioNTech appear to work slightly better for males than for females.
Both vaccines use tiny orbs, or nanoparticles, to deliver their active ingredients to cells in our immune systems. For years, Mahmoudi has been studying how and why nanomedicines therapies that use nanoparticles can affect patients differently based on their sex and he believes this could be a factor with the vaccines.
Researchers are studying and raising awareness about the role of sex in the efficacy of vaccines that use nanomedicine, including some COVID-19 vaccines.
If there’s one take-home message for the general public about the coronavirus vaccines approved in the US, it’s that they are remarkably effective.
But Michigan State University’s Morteza Mahmoudi is raising awareness about an important subtlety: The vaccines developed by Moderna and Pfizer-BioNTech appear to work slightly better for males than for females.
“We need to monitor these sex differences and report them to the scientific community and the public.”
Both vaccines use tiny orbs, or nanoparticles, to deliver their active ingredients to cells in our immune systems. For years, Mahmoudi has been studying how and why nanomedicines therapies that use nanoparticles can affect patients differently based on their sex and he believes this could be a factor with the vaccines.